With some of the biggest Biotech companies appearing to be forming topping formations, and the possibly of a further overall market correction, Biotech's could be hit hard as most valuations signal overvalued conditions.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
